Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Releases

222 Press Releases
DateTitleCompany
18 Apr 13 New type of bowel cancer discovered Cancer Research UK
17 Apr 13 Mercodia AB announces the signing of exclusive C-PEP3 licensing agreement with SBH Diagnostic Inc Mercodia AB
15 Apr 13 CPhI and PharmaEvolution.com to analyze pharma industry in monthly and annual reports CPhI and PharmaEvolution.com ,
Published by
DeFacto
12 Apr 13 Sanofi and PATH announce the Launch of Large-scale Production of Semisynthetic Artemisinin against Malaria Sanofi
12 Apr 13 Bristol-Myers Squibb Foundation, Morehouse School of Medicine Partner to Spread Lessons from Together on Diabetes™ Initiative Bristol-Myers Squibb
12 Apr 13 NICE seeks views on draft guidance for non-Hodgkin's lymphoma treatment NICE
12 Apr 13 Draft guidance from NICE says yes to ranibizumab for common eye condition NICE
12 Apr 13 Sanofi Pasteur’s New Quadrivalent Influenza Vaccine Accepted for Review for European Approval Sanofi Pasteur
12 Apr 13 Merck Announces FDA Acceptance of New Drug Application for an Investigational Tablet Formulation of the Antifungal NOXAFIL® (posaconazole) Merck
12 Apr 13 Abbott's Galectin-3 Test Provides Doctors in Europe with New Tool for Assessing the Prognosis of Chronic Heart Failure Patient Abbott
12 Apr 13 Actavis Reaches Agreements with Valeant to Launch Generic Versions of Ziana® and Zyclara® Actavis, Inc
12 Apr 13 Society for Brain Mapping and Therapeutics (SBMT) announce the formation of American Board of Brain Mapping, its 2013 award recipients and its Brain Mapping Day at the US Congress Society for Brain Mapping and Therapeutics (SBMT)
10 Apr 13 Mercodia and Profil Institute Announce Partnership Offering Insulin and Metabolism ELISA Assays to Enhance Diabetes and Obesity Clinical Trials Mercodia AB
10 Apr 13 ARIAD PRESENTS NEW PRECLINICAL DATA SHOWING PONATINIB OVERCOMES RESISTANT MUTATIONS IN KIT, AN ONCOGENIC DRIVER OF GASTROINTESTINAL STROMAL TUMORS ARIAD Pharmaceuticals, Inc,
Published by
Biosector 2
08 Apr 13 New PDUFA action date announced by the US FDA for Injectafer® New Drug Application Vifor Pharma ,
Published by
Vifor Pharma
08 Apr 13 Lundbeck announces positive results for Brintellix™ (vortioxetine) in adult patients with major depression and inadequate response to SSRI or SNRI therapy H. Lundbeck A/S,
Published by
Lundbeck
02 Apr 13 SUNOVION EUROPE ANNOUNCES NEW NAME Sunovion Pharmaceuticals Europe Ltd,
Published by
Munro & Forster
02 Apr 13 Update on Developmental and Clinical Activity ValiRx Plc,
Published by
ValiRx plc
02 Apr 13 Clavis Pharma announces negative outcome of Phase III CLAVELA trial with elacytarabine in patients with acute myeloid leukaemia Clavis Pharma
27 Mar 13 The latest breakthroughs in Adaptive Designs in Clinical Trials SMi Group
27 Mar 13 NICE has recently recommended omalizumab (Xolair, Novartis Pharmaceuticals UK) as an option for treating severe, persistent allergic asthma in adults, adolescents and children. The SMi Group ,
Published by
SMi Group Ltd
26 Mar 13 Shire to Acquire SARcode Bioscience, Expands Presence in Ophthalmology Shire ,
Published by
Shire
26 Mar 13 SAFEWARE QUASAR EXHIBITS AT CHEMSPEC EUROPE Safeware Quasar
26 Mar 13 Lundbeck and Otsuka further expand their alliance and enter into collaboration for the development and commercialization of Lu AE58054 in development for Alzheimer’s disease H. Lundbeck A/S ,
Published by
Lundbeck
26 Mar 13 Recipharm site in France approved for supply of manufactured products to Japan Recipharm AB,
Published by
DeFacto
25 Mar 13 Results of St. Jude Medical’s RESPECT Trial Published in The New England Journal of Medicine St. Jude Medical, Inc,
Published by
Chandler Chicco Agency
25 Mar 13 A new look for the Cetraben range of products for the treatment of dry skin and eczema Genus Pharmaceuticals ,
Published by
Packer Forbes Communications
25 Mar 13 Luke Johnson, leading entrepreneur, takes the helm at The Institute of Cancer Research The Institute of Cancer Research
22 Mar 13 ClinTec chosen for insight into global networking techniques in the world of international business ClinTec International,
Published by
DeFacto
22 Mar 13 EUROPEAN CHMP ADOPTS POSITIVE OPINION FOR STRIBILD®, A ONCE-DAILY, INTEGRASE INHIBITOR-BASED, SINGLE TABLET REGIMEN FOR THE TREATMENT OF HIV-1 INFECTION Gilead Sciences
Advertising